Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
Clinical trial NCT01393964 · COMPLETED
Trial details
- NCT number
- NCT01393964
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-06
- Primary completion
- 2014-03-21
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.